Let's connect at ASCO

June 3-7, 2022, Chicago, IL 

Learn how oncology's most powerful clinical development platform can help you deliver smarter trials and faster cures 

ASCOAM22

Phesi has the world's largest real-time clinical development database.  We deliver patient-centric data science that enables Pharma and Biotech companies to predict and optimize clinical development outcomes in oncology, for even the hardest to treat cancers like KRAS G12C NSCLC

Providing answers through 3 oncology service offers: 

Patient_population

Digital patient profile / digital twin / synthetic control arm

Investigator

Protocol design optimizer

Clinsite_country_1

Country & Investigator site allocation

Come and talk to us at booth 5033 

Pre-book a 30 minute meeting with our President and Founder, Gen Li
See first-hand how we deliver data, insights and answers, enabling smarter trials and
faster cures in oncology 

Pre-book a 30 minute meeting below

Clinical trials and the quest for answers

Our patient-centric data science helps deliver faster cures

Ukraine_newsletter

Global impact of Ukraine and Russia war on clinical development

Breast cancer

Only 14% of breast cancer trials reach optimal enrolment targets

Digital_twin

A Digital Twin on KRAS G12C NSCLC Patients with SCA Measured by PFS